Publications for Stina Axelsson
Co-author map based on ISI articles 2007-
Publications mentioned in social media 4 times*
Journal Articles
Mikael Pihl, Linda Åkerman, Stina Axelsson, Mikael Chéramy, Maria Hjorth, R. Mallone, Johnny Ludvigsson and Rosaura Casas
Regulatory T cell phenotype and function 4 years after GADalum treatment in children with type 1 diabetes
Clinical and Experimental Immunology, 2013, 172(3), 394-402.
|
Stina Axelsson, Maria Hjorth, Johnny Ludvigsson and Rosaura Casas
Decreased GAD(65) -specific Th1/Tc1 phenotype in children with Type 1 diabetes treated with GAD-alum.
Diabetic Medicine, 2012, 29(10), 1272-1278.
Fulltext  |
Stina Axelsson, Mikael Chéramy, Maria Hjorth, Mikael Pihl, Linda Åkerman, Emanuela Martinuzzi, Roberto Mallone, Johnny Ludvigsson and Rosaura Casas
Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
PLoS ONE, 2011, 6(12), .
Fulltext Web of Science® Times Cited: 6 |
Johnny Ludvigsson, Maria Hjorth, Mikael Chéramy, Stina Axelsson, Mikael Pihl, G Forsander, N-O Nilsson, B-O Samuelsson, T Wood, J Aman, E Ortqvist and Rosaura Casas
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
DIABETOLOGIA, 2011, 54(3), 634-640.
Fulltext Web of Science® Times Cited: 20 |
Maria Hjorth, Stina Axelsson, Anna Ryden, Maria Faresjo, Johnny Ludvigsson and Rosaura Casas
GAD-alum treatment induces GAD(65)-specific CD4(+)CD25(high)FOXP3(+) cells in type 1 diabetic patients
CLINICAL IMMUNOLOGY, 2011, 138(1), 117-126.
Web of Science® Times Cited: 10 |
Stina Axelsson, Maria Hjorth, Linda Åkerman, Johnny Ludvigsson and Rosaura Casas
Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65)
Diabetes/Metabolism Research Reviews, 2010, 26(7), 559-568.
Web of Science® Times Cited: 9 |
Johnny Ludvigsson, Maria Faresjö, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl, Outi Vaarala, Gun Forsander, Sten Ivarsson, Calle Johansson, Agne Lindh, NO Nilsson, Jan Åman, Eva Örtqvist, Peter Zerhouni and Rosaura Casas
GAD treatment and insulin secretion in recent-onset type 1 diabetes
New England Journal of Medicine, 2008, 359(18), 1909-1920.
Web of Science® Times Cited: 191 |
Maria Hedman Hjorth, Maria Faresjö, Stina Axelsson, Johnny Ludvigsson and Rosaura Casas
Impaired CD4+ and CD8+ T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children
Clinical and Experimental Immunology, 2008, 153(3), 360-368.
Fulltext Web of Science® Times Cited: 9 |
Stina Axelsson, Maria Faresjö, Maria Hedman, Johnny Ludvigsson and Rosaura Casas
Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children
Cryobiology, 2008, 57(3), 201-208.
Web of Science® Times Cited: 12 |
Conference Articles
E Martinuzzi, M C Gagnerault, S Fourlanos, L Harrison, Stina Axelsson, Mikael Chéramy, Johnny Ludvigsson, Rosaura Casas and R Mallone
Why are the benefits of vaccinations in the helping of beta-cellular antigenes in type 1 diabetes so limited? An analysis of linked immunological biomarkers in DIABETES and METABOLISM, vol 38, issue 2, pp A5-A5
DIABETES and METABOLISM, 2012.
|
Rosaura Casas, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl and Johnny Ludvigsson
Specific immunomodulatory effect of GAD(65) in type 1 diabetics
in DIABETOLOGIA, vol 52, 2009.
|
Maria Hjorth, Stina Axelsson, Johnny Ludvigsson and Rosaura Casas
GAD-alum treatment induces GAD-specific FOXP3+ cells in type 1 diabetic children
in DIABETOLOGIA, vol 52, 2009.
|
Stina Axelsson, Maria Hjorth, L Akerman, Johnny Ludvigsson and Rosaura Casas
Treatment with alum-formulated GAD65 in type 1 diabetic children results in early induction of Th2 responses
in DIABETOLOGIA, vol 52, 2009.
|
Ph.D. Theses
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.
Ph.D., Lic. Theses
